An open-label extension trial shows symptom improvement in schizophrenia with long-term treatment, indicating positive outcomes.
Long-term treatment with X/T over 52 weeks was safe, generally well tolerated, and associated with durable symptom improvement in people with schizophrenia.
No takes yet. Share an insight, caveat, or question.
Kaul et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: